XBP-1, an important branch of the URP during ERS activation, has been regarded as a crucial target for anti-cancer strategies, as genetic inhibition of XBP-1 resulted in diminished tumor growth, and several compound, obtained from a small molecule screen for inhibitors of XBP-1 activation, exhibited potential anti-tumor activity [28]. This evidence concerns the gene XBP1 and cancer.